Improved efficacy of meglumine antimoniate incorporated in anionic liposomes against Leishmania infantum infecting canine macrophages
- 21 July 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 74 (6) , 896-904
Abstract
Leishmaniasis is a zoonotic disease and several drugs have been used in the treatment, including meglumine antimoniate (AME). The chemotherapy reaches clinical cure but does not eliminate parasites, contributing to drug resistance. To improve AME efficacy we incorporated it in anionic liposomes. The antiparasitic activity and intracellular localization were investigated in canine macrophages infected with Leishmania infantum. Liposomes (L-AME) is composed of egg phosphatidylcholine, cholesterol, palmitoyl oleoyl phosphatidyl serine and α-tocopherol (4 : 3 : 0.4 : 0.07 mol%) plus AME. L-AME size, polydispersity, zeta potential and morphology were analysed as well as antileishmanial activity and intracellular localization in DH82 macrophages. Liposomes (360 nm) zeta potential range from −40 to −65 mV, had 23% encapsulation efficiency and were stable for 180 days at 4°C. Free AME was cytotoxic towards L. infantum infected macrophages (ID50 = 0.012 M) while L-AME did not reduce cell viability. L-AME colocalized with parasites inside macrophages in a time-dependent manner, and reduced the percentage of infected cells and the number of intracellular parasites, decreasing the infection index (75–80%) twice as compared with AME treatment. Liposomal AME is a promising delivery system for treating visceral leishmaniasis, improving meglumine efficacy against L. infantum and minimizing its cytotoxicity towards canine macrophagesKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/01536-1)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/12443-7)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/23767-0)
- Conselho Nacional de Pesquisa (309625/2017-3)
This publication has 34 references indexed in Scilit:
- Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous LeishmaniasisPLOS Neglected Tropical Diseases, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Leishmania promastigotes: building a safe niche within macrophagesFrontiers in Cellular and Infection Microbiology, 2012
- Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinolThe Veterinary Journal, 2011
- Pentavalent Antimonials: New Perspectives for Old DrugsMolecules, 2009
- Retooling Leishmania metabolism: from sand fly gut to human macrophageThe FASEB Journal, 2007
- A guided tour into subcellular colocalization analysis in light microscopyJournal of Microscopy, 2006
- Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserineJournal of Antimicrobial Chemotherapy, 2004
- Co‐localization analysis of complex formation among membrane proteins by computerized fluorescence microscopy: application to immunofluorescence co‐patching studiesJournal of Microscopy, 2003
- Possibility of heat sterilization of liposomes.Chemical and Pharmaceutical Bulletin, 1991